keyword
https://read.qxmd.com/read/38701914/integrating-molecular-and-radiological-screening-tools-during-community-based-active-case-finding-for-tuberculosis-and-covid-19-in-southern-africa
#1
JOURNAL ARTICLE
Alex John Scott, Mohammed Limbada, Tahlia Perumal, Shameem Jaumdally, Andrea Kotze, Charnay van der Merwe, Maina Cheeba, Deborah Milimo, Keelin Murphy, Bram van Ginneken, Mariana de Kock, Robin Mark Warren, Phindile Gina, Jeremi Swanepoel, Louié Kühn, Suzette Oelofse, Anil Pooran, Aliasgar Esmail, Helen Ayles, Keertan Dheda
OBJECTIVES: To evaluate diagnostic yield and feasibility of integrating testing for TB and COVID-19 using molecular and radiological screening tools during community-based active case-finding (ACF). METHODS: Community-based participants with presumed TB and/or COVID-19 were recruited using a mobile clinic. Participants underwent simultaneous point-of-care (POC) testing for TB (sputum; Xpert-Ultra) and COVID-19 (nasopharyngeal swabs; Xpert-SARS-CoV-2). Sputum culture and SARS-CoV-2 RT-PCR served as reference standards...
May 1, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38701846/undiagnosed-hiv-in-patients-on-immunosuppressive-medications-presenting-with-hiv-associated-kidney-disease
#2
JOURNAL ARTICLE
Nathaniel Forrester, Jonathan Zhang Suo Keyes, Ronan Cajimat, Yelena Burklin, Mary Ann Kirkconnell Hall, Jason Cobb
Approximately 158,500 adults and adolescents in the United States live with undiagnosed human immunodeficiency virus (HIV). Missed or delayed diagnoses adversely affect disease management and outcomes. This is particularly salient for patients receiving immunosuppressive and immunomodulatory therapy for the management of chronic inflammatory conditions, in which additional immunosuppression may increase the risk and severity of opportunistic infections. Despite this risk, comprehensive HIV testing before the initiation of immunosuppressive therapy is not yet the norm...
May 2024: Southern Medical Journal
https://read.qxmd.com/read/38691024/risk-score-prediction-for-bacteriologically-confirmed-tuberculosis-among-hiv-infected-adults-on-antiretroviral-therapy-in-ethiopia-prognostic-model-development
#3
JOURNAL ARTICLE
Nebiyu Mekonnen Derseh, Muluken Chanie Agimas, Tigabu Kidie Tesfie
OBJECTIVE: This study was aimed at developing a risk score prediction model for bacteriologically confirmed TB among HIV-infected adults receiving antiretroviral therapy in Ethiopia. METHODS: An institutional-based retrospective follow-up study was conducted among 569 HIV-infected adults on ART. We used demographic and clinical prognostic factors to develop a risk prediction model. Model performance was evaluated by discrimination and calibration using the area under the receiver operating characteristic (AUROC) curve and calibration plot...
April 25, 2024: AIDS
https://read.qxmd.com/read/38685106/correction-presence-of-tuberculosis-symptoms-among-hiv-positive-men-who-have-sex-with-men-msm-in-zimbabwe
#4
Munyaradzi Mapingure, Innocent Chingombe, Tafadzwa Dzinamarira, Brian Moyo, Chesterfield Samba, Delight Murigo, Owen Mugurungi, Elliot Mbunge, Rutendo Birri Makota, Grant Murewanhema, Godfrey Musuka
No abstract text is available yet for this article.
April 29, 2024: AIDS Research and Therapy
https://read.qxmd.com/read/38681350/a-case-of-extensive-tuberculosis-with-bacterial-infection-treated-in-a-peripheral-hospital
#5
Maxim Suleac, Ana Rezende, Socrates Naranjo, Malam Djassi
Since 1997, the World Health Organization (WHO) publishes the Global Tuberculosis Report every year, which contains the most up-to-date and accurate statistical data on tuberculosis (TB) worldwide. TB is an infectious disease that is one of the leading causes of human morbidity. It ranks among the top 10 most common causes of death worldwide and is more likely than other pathogens, such as the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), to result in a fatal outcome...
March 2024: Curēus
https://read.qxmd.com/read/38676589/vaccination-against-respiratory-tract-pathogens-in-primary-immune-deficiency-patients-receiving-immunoglobulin-replacement-therapy
#6
JOURNAL ARTICLE
Makbule Seda Bayrak Durmaz, Reyhan Yıldız, Göksal Keskin, Seda Altıner
INTRODUCTION: Inborn errors of immunity (IEI) increase morbidity and mortality risks, particularly from respiratory tract infections. Hence, vaccination becomes pivotal for IEI patients. This study aims to examine the vaccination and respiratory tract infection rates in a diverse IEI patient cohort undergoing immunoglobulin replacement therapy (IGRT). MATERIALS AND METHODS: We retrospectively evaluated IEI patients on IGRT at a tertiary care center. Data on vaccinations and respiratory infections were extracted from medical records...
March 2024: Tüberküloz Ve Toraks
https://read.qxmd.com/read/38675968/trends-in-and-risk-factors-for-drug-resistance-in-mycobacterium-tuberculosis-in-hiv-infected-patients
#7
JOURNAL ARTICLE
Xiaoqin Le, Xueqin Qian, Li Liu, Jianjun Sun, Wei Song, Tangkai Qi, Zhenyan Wang, Yang Tang, Shuibao Xu, Junyang Yang, Jiangrong Wang, Jun Chen, Renfang Zhang, Zhaoqin Zhu, Yinzhong Shen
Trends in and risk factors for drug resistance in Mycobacterium tuberculosis ( M. tuberculosis ) in human immunodeficiency virus (HIV)-infected patients with active tuberculosis were analyzed. The clinical data of M. tuberculosis and HIV-coinfected patients treated at the Shanghai Public Health Clinical Center between 2010 and 2022 were collected. The diagnosis of tuberculosis was confirmed by solid or liquid culture. The phenotypic drug susceptibility test was carried out via the proportional method, and the resistance to first-line and second-line drugs was analyzed...
April 18, 2024: Viruses
https://read.qxmd.com/read/38675837/advances-in-antiretroviral-therapy-for-patients-with-human-immunodeficiency-virus-associated-tuberculosis
#8
REVIEW
Xiaoqin Le, Yinzhong Shen
Tuberculosis is one of the most common opportunistic infections and a prominent cause of death in patients with human immunodeficiency virus (HIV) infection, in spite of near-universal access to antiretroviral therapy (ART) and tuberculosis preventive therapy. For patients with active tuberculosis but not yet receiving ART, starting ART after anti-tuberculosis treatment can complicate clinical management due to drug toxicities, drug-drug interactions and immune reconstitution inflammatory syndrome (IRIS) events...
March 23, 2024: Viruses
https://read.qxmd.com/read/38672487/htpg-a-major-virulence-factor-and-a-promising-vaccine-antigen-against-mycobacterium-tuberculosis
#9
REVIEW
Rita Berisio, Giovanni Barra, Valeria Napolitano, Mario Privitera, Maria Romano, Flavia Squeglia, Alessia Ruggiero
Tuberculosis (TB) is the leading global cause of death f rom an infectious bacterial agent. Therefore, limiting its epidemic spread is a pressing global health priority. The chaperone-like protein HtpG of M. tuberculosis (Mtb) is a large dimeric and multi-domain protein with a key role in Mtb pathogenesis and promising antigenic properties. This dual role, likely associated with the ability of Heat Shock proteins to act both intra- and extra-cellularly, makes HtpG highly exploitable both for drug and vaccine development...
April 11, 2024: Biomolecules
https://read.qxmd.com/read/38670256/recent-advances-in-the-development-of-dpre1-inhibitors-using-ai-cadd-approaches
#10
REVIEW
Kepeng Chen, Ruolan Xu, Xueping Hu, Dan Li, Tingjun Hou, Yu Kang
Tuberculosis (TB) is a global lethal disease caused by Mycobacterium tuberculosis (Mtb). The flavoenzyme decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1) plays a crucial part in the biosynthesis of lipoarabinomannan and arabinogalactan for the cell wall of Mtb and represents a promising target for anti-TB drug development. Therefore, there is an urgent need to discover DprE1 inhibitors with novel scaffolds, improved bioactivity and high drug-likeness. Recent studies have shown that artificial intelligence/computer-aided drug design (AI/CADD) techniques are powerful tools in the discovery of novel DprE1 inhibitors...
April 24, 2024: Drug Discovery Today
https://read.qxmd.com/read/38659142/facilitators-and-barriers-to-adolescent-participation-in-a-tb-clinical-trial
#11
MULTICENTER STUDY
J M Mangan, K N C Hedges, M M Salerno, K Tatum, B Bouwkamp, M W Frick, L McKenna, G Muzanyi, M Engle, J Coetzee, J Yvetot, M Elskamp, D Lamunu, M E Theunissen Tizora, D Namutamba, R E Chaisson, S Swindells, P Nahid, S E Dorman, E Kurbatova
<sec id="st1"><title>BACKGROUND</title>The inclusion of adolescents in TB drug trials is essential for the development of safe, child-friendly regimens for the prevention and treatment of TB. TB Trials Consortium Study 31/AIDS Clinical Trials Group A5349 (S31/A5349) enrolled adolescents as young as 12 years old. We assessed investigator and coordinator described facilitators and barriers to adolescent recruitment, enrollment, and retention.</sec><sec id="st2"><title>METHODS</title>Interviews were conducted with six investigators from sites that enrolled adolescent participants and six investigators from non-enrolling sites...
May 1, 2024: International Journal of Tuberculosis and Lung Disease
https://read.qxmd.com/read/38656226/structural-and-functional-characterization-of-fabg4-from-mycolicibacterium-smegmatis
#12
JOURNAL ARTICLE
Xinping Ran, Prashit Parikh, Jan Abendroth, Tracy L Arakaki, Matthew C Clifton, Thomas E Edwards, Donald D Lorimer, Stephen Mayclin, Bart L Staker, Peter Myler, Krystle J McLaughlin
The rise in antimicrobial resistance is a global health crisis and necessitates the development of novel strategies to treat infections. For example, in 2022 tuberculosis (TB) was the second leading infectious killer after COVID-19, with multi-drug-resistant strains of TB having an ∼40% fatality rate. Targeting essential biosynthetic pathways in pathogens has proven to be successful for the development of novel antimicrobial treatments. Fatty-acid synthesis (FAS) in bacteria proceeds via the type II pathway, which is substantially different from the type I pathway utilized in animals...
April 1, 2024: Acta Crystallographica. Section F, Structural Biology Communications
https://read.qxmd.com/read/38656045/clusters-of-heterogeneity-of-tuberculosis-hiv-coinfection-in-brazil-a-geospatial-study
#13
JOURNAL ARTICLE
Lucas Vinícius de Lima, Gabriel Pavinati, Pedro Augusto Bossonario, Aline Aparecida Monroe, Daniele Maria Pelissari, Kleydson Bonfim Andrade Alves, Gabriela Tavares Magnabosco
OBJECTIVE: To analyze the geospatialization of tuberculosis-HIV coinfection in Brazil, from 2010 to 2021, and the correlation with socioeconomic, housing, and health indicators. METHODS: An ecological study of Brazilian municipalities and states, with data from HIV and tuberculosis information systems, previously reported by the Ministry of Health. The crude and smoothed coefficients were calculated by the local empirical Bayesian method of incidence of coinfection per 100,000 inhabitants in the population aged between 18 and 59 years...
2024: Revista de Saúde Pública
https://read.qxmd.com/read/38644511/pulmonary-dimorphic-fungal-infections-among-hiv-aids-non-tb-patients-with-chronic-cough-in-kampala-uganda
#14
JOURNAL ARTICLE
Prossy Kiconco, Beatrice Achan, Moses Sanya, Irene Najjingo, Alfred Okeng, Freddie Bwanga
INTRODUCTION: Dimorphic fungi cause infection following the inhalation of spores into the pulmonary system. In the lower respiratory tract, the conidia transform into yeasts, which are engulfed by alveolar macrophages and may be destroyed without disease manifestation. However, in some immunocompromised individuals, they may persist and cause active fungal disease characterized by formation of granulomas in the infected tissues, which may mimic Mycobacterium tuberculosis (MTB). OBJECTIVE: To determine the prevalence of pulmonary dimorphic fungal infections among HIV/AIDS patients with non-TB chronic cough at Mulago National Referral and Teaching Hospital in Kampala, Uganda...
April 2024: Mycoses
https://read.qxmd.com/read/38640940/global-burden-associated-with-85-pathogens-in-2019-a-systematic-analysis-for-the-global-burden-of-disease-study-2019
#15
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Despite a global epidemiological transition towards increased burden of non-communicable diseases, communicable diseases continue to cause substantial morbidity and mortality worldwide. Understanding the burden of a wide range of infectious diseases, and its variation by geography and age, is pivotal to research priority setting and resource mobilisation globally. METHODS: We estimated disability-adjusted life-years (DALYs) associated with 85 pathogens in 2019, globally, regionally, and for 204 countries and territories...
April 16, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38637892/exploring-the-association-between-erythema-multiforme-and-hiv-infection-some-mechanisms-and-implications
#16
REVIEW
Shumani Charlotte Manenzhe, Razia Abdool Gafaar Khammissa, Sindisiwe Londiwe Shangase, Mia Michaela Beetge
Erythema multiforme (EM) is an immune-mediated mucocutaneous condition characterized by hypersensitivity reactions to antigenic stimuli from infectious agents and certain drugs. The most commonly implicated infectious agents associated with EM include herpes simplex virus (HSV) and Mycoplasma pneumoniae. Other infectious diseases reported to trigger EM include human immunodeficiency virus (HIV) infection and several opportunistic infections. However, studies focusing on EM and human immunodeficiency virus (HIV) infection are scarce...
April 18, 2024: AIDS Research and Therapy
https://read.qxmd.com/read/38636244/factors-affecting-in-hospital-mortality-in-patients-with-miliary-tuberculosis-a-retrospective-cohort-study
#17
JOURNAL ARTICLE
Jumpei Taniguchi, Shotaro Aso, Taisuke Jo, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga
BACKGROUND: Miliary tuberculosis (TB) is a fatal disease; thus, prompt diagnosis and immediate intervention are indispensable. However, the risk factors for in-hospital mortality in patients with miliary TB remain unclear. Therefore, this study aimed to identify the factors associated with in-hospital mortality in patients with miliary TB using a Japanese nationwide inpatient database. METHODS: Patients diagnosed with miliary TB between July 2010 and March 2022 were enrolled from the Diagnosis Procedure Combination database...
April 17, 2024: Respiratory Investigation
https://read.qxmd.com/read/38635618/knowledge-attitudes-and-practice-toward-tuberculosis-in-high-school-students-in-qingdao-china
#18
JOURNAL ARTICLE
Xiaoqi Dai, Shuo Li, Song Song, Meng Chen, Honghong Xu, Xuekui Li, Menghan Zhang, Huaqiang Zhang, Haiyan Sun, Zhongdong Wang
INTRODUCTION: The purpose of this study is to assess the levels of knowledge, attitude, and practice (KAP) related to TB, and to analyze the differences among various demographic groups. METHODOLOGY: A total of 621 students enrolled in Qingdao High School, coming from high TB burden settings. The cross-sectional study was conducted from May to July of 2022. Participants completed an online questionnaire. Differences in knowledge and practice based on participant characteristics were analyzed using the Wilcoxon rank test and Kruskal-Wallis rank test...
March 31, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38633442/how-reliable-is-chatgpt-as-a-novel-consultant-in-infectious-diseases-and-clinical-microbiology
#19
JOURNAL ARTICLE
Gülşah Tunçer, Kadir Görkem Güçlü
OBJECTIVE: The study aimed to investigate the reliability of ChatGPT's answers to medical questions, including those sourced from patients and guide recommendations. The focus was on evaluating ChatGPT's accuracy in responding to various types of infectious disease questions. MATERIALS AND METHODS: The study was conducted using 200 questions sourced from social media, experts, and guidelines related to various infectious diseases like urinary tract infection, pneumonia, HIV, various types of hepatitis, COVID-19, skin infections, and tuberculosis...
March 2024: Infect Dis Clin Microbiol
https://read.qxmd.com/read/38633009/opportunistic-infections-among-human-immunodeficiency-virus-hiv-infected-patients-in-turkey-a-systematic-review
#20
REVIEW
Uğur Önal, Halis Akalın
This study aimed to identify opportunistic infections among human immunodeficiency virus (HIV) infected patients in Turkey. Therefore, we conducted a systematic literature review of the studies published up to October 1, 2022, in the Pubmed, Web of Science (WoS), and ULAKBİM TR Dizin databases. We searched for medical subject headings (MeSH) terms of (HIV) OR (AIDS) OR (human immunodeficiency virus) AND (opportunistic infections) AND (Turkey). Fifty-five studies in Pubmed, 68 in WoS, and 212 in ULAKBİM TR Dizin were listed with these keywords...
June 2023: Infect Dis Clin Microbiol
keyword
keyword
30359
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.